You are currently viewing a new version of our website. To view the old version click .
MDPIMDPI
Search all articles
Chemistry Proceedings
Download PDF
  • Proceeding Paper
  • Open Access

14 November 2022

Semisynthesis of 6β-Acetoxyvouacapane Derivatives via the Ugi-Azide Multicomponent Reaction †

,
,
,
,
,
,
and
1
Laboratorio de Diseño Molecular, Instituto de Investigaciones Químico Biológicas, Universidad Michoacana de San Nicolás de Hidalgo, Ciudad Universitaria, Morelia 58030, Mexico
2
Laboratorio de Química de Productos Naturales, Instituto de Investigaciones Químico Biológicas, Universidad Michoacana de San Nicolás de Hidalgo, Ciudad Universitaria, Morelia 58030, Mexico
3
Instituto Politécnico Nacional, Unidad Profesional Interdisciplinaria de Ingeniería Campus Guanajuato, Av. Mineral de Valenciana 200 Col. Fracc. Industrial Puerto Interior, Silao 36275, Mexico
*
Authors to whom correspondence should be addressed.
Chem. Proc.2022, 12(1), 24;https://doi.org/10.3390/ecsoc-26-13552
This article belongs to the Proceedings The 26th International Electronic Conference on Synthetic Organic Chemistry
Version Notes
Order Reprints

Abstract

A semisynthesis of 6β-acetoxyvouacapane-1,5-disusbtituted tetrazoles derivatives from the leaves of Caesalpinia platyloba by using the Ugi-azide multicomponent reaction as a key step reaction is described. To our knowledge, this is the first report where a non-natural product such as 1,5-disusbtituted tetrazole has been linked to a natural product or derivate of a natural product, and beyond the biological relevance that the target molecules present, this work contributes to the area of natural products as well as multicomponent reactions.

1. Introduction

Natural products, besides their complex molecular architecture and structural diversity, exhibit several biological properties; thus, they have become a source of inspiration in the development of drug substances []. Likewise, extracts from natural sources play an important role as additives in the food, cosmetic, textile, and perfume industries []. On the other hand, the greatest source of natural products is terrestrial vascular plants, followed by marine plants and microorganisms such as bacteria and fungi, of which only 1% of the total microbial world has been studied. It has been calculated that of around 75,000 species of higher plants on the earth, only 10% have been used in traditional medicine. Only 1 to 5% have been studied scientifically and are known to have therapeutic value [].
Nowadays, it has become a challenging task to synthesize chemical libraries for drug discovery based on natural products in a simple and efficient way. There are many strategies to accomplish this challenge, of which multicomponent reactions are one of the most important. Multicomponent reactions are synthetic tools well known for their potential to generate complexity and structural diversity under a one pot process, which results in the formation of at least three new bonds per operation and high atomic economy [,,].
On the other hand, the Caesalpinia genus constitutes a potential source of bioactive natural products due to its more than 205 species distributed throughout the world [], many of which have not yet been investigated for potential pharmacological activity. Several species are endemic to Mexico and exhibit a diversity of biological activities such as cytotoxic, antioxidant, antimalarial, anti-inflammatory, and antiviral []. The Caesalpinia genus is distinguished by the presence of diterpenes, with a vouacapane skeleton, which is characterized by containing a furan ring in its skeletal structure. Some examples of natural products (1–6) isolated from this genus are shown in Figure 1, where 6β-acetoxivouacapane 7 is the natural product under study in this work, and it was isolated from Caesalpinia platyloba [].
Figure 1. Vouacapanes isolated from the genus Caesalpinia.
Therefore, in this work the synthesis of a small series of derivatives of the natural product 6β-acetoxyvouacapane 7, by using the Ugi-azide multicomponent reaction, is described. It is important to mention that, within the state of the art, there are very few reports where a natural product is used as a starting material making use of RMC-I and, particularly, there are no reports on the use of the Ugi-azide reaction where a natural product or its derivatives are used as a starting material. Therefore, this work will contribute to the chemistry of natural products and the chemistry of multicomponent reactions.

2. Materials and Methods

2.1. Experimental Section

All reagents, reactants, and solvents were purchased from Merck (before Sigma-Aldrich Co) without further purification. Thin-layer chromatography (TLC) was performed with silica gel plates from Merck (silica gel 60 F 254) and by using as eluent a mixture of hexanes-EtOAc, and NMR spectra were recorded at 400   MHz for 1H and 100   MHz for 13C on a Varian Mercury 400 spectrometer, using CDCl3 as the solvent and TMS as the internal standard. The chemical shift (δ) is reported in ppm, and the J values are given in Hertz. The chemical names and drawings were obtained using ChemDraw Professional (version 15.0.0.106).

2.2. General Procedure for 1,5-Disubstituted Tetrazoles-Vouacapane 12a–c

Aldehyde-6β-acetoxyvouacapane 8 (1.0 equiv.) and amine (1.0 equiv.) were dissolved on 2,2,2-trifluroethanol (1 M) in a 5 mL round-bottom flask and reacted for 5 min at room temperature. Then, isocyanide (1.0 equiv.) and TMSN3 (1.3 equiv.) were sequentially added. The reaction mixture was stirred at room temperature until reaction consumption by TLC. Later, the reaction mixture was evaporated under reduce pressure. Then, the evaporated reaction crude was purified by flash column chromatographic (4:1 Hex:EtOAc v/v) to afford the 1,5-disubstituted tetrazoles-vouacapane 12a–c.
(5R,6aS,7R,11aS,11bR)-9-((1-(tert-butyl)-1H-tetrazol-5-yl)(p-tolylamino)methyl)-4,4,7,11b-tetramethyl-1,2,3,4,4a,5,6,6a,7,11,11a,11b-dodecahydrophenanthro [3,2-b]furan-5-yl acetate (12a):
Yellow oil; RF = 0.40 (Hex:EtOAc 8:2 v/v);1H-NMR (400 MHz, CDCl3): Diast a. δ 6.99 (d, J = 8.3 Hz, 1H), 6.67 (d, J = 8.3 Hz, 1H), 6.13 (s, 1H), 5.99 (s, 1H), 5.48 (s, 1H), 2.59–2.36 (m, 3H), 2.22 (s, 1H), 2.03 (s, 1H), 2.02 (s, 3H), 1.80 (dt, J = 6.7, 3.6 Hz, 1H), 1.74 (s, 1H), 1.72 (s, 9H), 1.61 (d, J = 13.2 Hz, 1H), 1.57–1.54 (m, 1H), 1.53–1.48 (m, 1H),1.46–1.42 (m, 1H), 1.40–1.36 (m, 1H), 1.18 (s, 3H), 1.16–1.14 (m, 1H), 1.06 (s, 1H), 1.01 (s, 1H), 0.97 (s, 3H), 0.86 (d, J = 7.4 Hz, 3H). Diast b. δ = 6.99 (d, J = 8.2 Hz, 1H), 6.67 (d, J = 8.3 Hz, 1H), 6.11 (s, 1H), 5.96 (s, 1H), 5.48 (s, 1H), 2.59–2.36 (m, 3H), 2.22 (s, 1H), 2.03 (s, 1H), 2.02 (s, 3H), 1.80 (dt, J = 6.7, 3.6 Hz, 1H), 1.74 (s, 1H), 1.72 (s, 9H), 1.61 (d, J = 13.2 Hz, 1H), 1.57–1.54 (m, 1H), 1.53–1.48 (m, 1H), 1.46–1.42 (m, 1H), 1.40–1.36 (m, 1H), 1.18 (s, 3H), 0.86 (d, J = 7.4 Hz, 3H). 13C-NMR (100 MHz, CDCl3): (mixture of diasteromers) δ 170.5, 154.08, 154.06, 150.3, 150.2, 148.7, 148.6, 143.3, 130.1, 129.8, 128.89, 128.88, 123.3, 123.2, 121.0, 115.0, 114.9, 113.5, 108.8, 108.7, 69.5, 69.3, 69.1, 61.8, 61.7, 55.33, 55.30, 55.2, 55.1, 53.8, 53.5, 49.74, 49.68, 45.5, 45.1, 43.7, 43.64, 43.62, 42.22, 42.20, 42.0, 41.9, 37.92, 37.89, 37.85, 37.8, 37.7, 36.19, 36.17, 36.0, 35.9, 35.50, 35.45, 35.3, 35.2, 33.8, 33.79, 33.69, 33.65, 30.9, 30.84, 30.80, 30.0, 29.6, 29.2, 29.1, 29.0, 23.4, 21.8, 21.76, 21.70, 20.4, 18.8, 18.7, 17.5, 17.4, 17.20, 17.14.
(5R,6aS,7R,11aS,11bR)-9-((1-(tert-butyl)-1H-tetrazol-5-yl)(prop-2-yn-1-ylamino)methyl)-4,4,7,11b-tetramethyl-1,2,3,4,4a,5,6,6a,7,11,11a,11b-dodecahydrophenanthro [3,2-b]furan-5-yl acetate (12b):
Yellow oil; RF = 0.46 (Hex:EtOAc 6:4 v/v); 1H-NMR (400 MHz, CDCl3): Diast a. δ = 5.94 (s, 1H), 5.62 (s, 1H), 5.49 (s, 1H), 3.54 (dt, J = 16.8, 2.6 Hz, 2H), 2.61–2.40 (m, 3H), 2.23 (t, J = 2.4 Hz, 1H), 2.03 (s, 1H), 2.02 (s, 3H), 1.81 (dt, J = 6.5, 4.2 Hz, 1H), 1.73 (d, J = 2.6 Hz, 1H), 1.72 (s, 9H), 1.64–1.59 (m, 1H), 1.56–1.51 (m, 1H), 1.50–1.48 (m, 1H), 1.47–1.46 (m, 1H), 1.42–1.38 (m, 1H), 1.19 (s, 3H), 1.17–1.14 (m, 1H), 1.06 (s, 1H), 1.02 (s, 3H), 0.98 (s, 3H), 0.89 (d, J = 7.1 Hz, 3H). Diast b. δ = 5.90 (s, 1H), 5.62 (s, 1H), 5.49 (s, 1H), 3.45–3.39 (m, 2H), 2.61–2.40 (m, 3H), 2.23 (t, J = 2.4 Hz, 1H), 2.03 (s, 1H), 2.02 (s, 3H), 1.81 (dt, J = 6.5, 4.2 Hz, 1H), 1.73 (d, J = 2.6 Hz, 1H), 1.71 (s, 9H), 1.64–1.59 (m, 1H), 1.56–1.51 (m, 1H), 1.50–1.48 (m, 1H), 1.47–1.46 (m, 1H), 1.42–1.38 (m, 1H), 1.18 (s, 3H), 1.17–1.14 (m, 1H), 1.06 (s, 1H), 1.02 (s, 3H), 0.98 (s, 3H), 0.86 (d, J = 7.1 Hz, 3H). 13C-NMR (100 MHz, CDCl3): (mixture of diasteromers) δ 170.5, 153.8, 150.5, 148.6, 123.2, 109.1, 80.7, 72.6, 69.5, 61.6, 55.4, 55.3, 51.1, 45.5, 43.6, 42.2, 37.9, 36.2, 33.8, 33.7, 30.90, 30.88, 30.0, 29.9, 29.7, 23.4, 21.8, 18.7, 17.5, 17.2, 17.1.
Ethyl 5-((((5R,6aS,7R,11aS,11bR)-5-acetoxy-4,4,7,11b-tetramethyl-1,2,3,4,4a,5,6,6a,7,11,11a,11b-dodecahydrophenanthro [3,2-b]furan-9-yl)(1-(tert-butyl)-1H-tetrazol-5-yl)methyl)amino)benzofuran-2-carboxylate (12c):
Yellow oil; RF = 0.56 (Hex:EtOAc 6:4 v/v); 1H-NMR (400 MHz, CDCl3): Diast a. δ 7.43–7.37 (m, 2H), 6.97–6.93 (m, 2H), 6.15 (s, 1H), 6.00 (s, 1H), 5.49 (s, 1H), 4.42 (q, J = 7.1 Hz, 2H), 2.59–2.41 (m, 3H), 2.05.2.02 (m, 1H), 2.01 (s, 3H), 1.80 (dt, J = 5.8, 2.5 Hz, 1H), 1.72 (s, 1H). 1.68–1.65 (m, 1H), 1.64–1.61 (m, 1H), 1.55–1.53 (m, 1H), 1.50–1.47 (m, 1H), ), 1.44–1.42 (m, 1H), 1.41 (t, J = 7.1 Hz, 3H), 1.22–1.20 (m, 1H), 1.18 (s, 3H), 1.06 (s, 1H), 1.01 (s, 3H), 0.98 (s, 3H), 0.88 (d, J = 7.3 Hz, 3H). Diast b. δ 7.43–7.37 (m, 2H), 6.97–6.93 (m, 2H), 6.15 (s, 1H), 5.97 (s, 1H), 5.49 (s, 1H), 4.42 (q, J = 7.1 Hz, 2H), 2.59–2.41 (m, 3H), 2.05.2.02 (m, 1H), 2.01 (s, 3H), 1.80 (dt, J = 5.8, 2.5 Hz, 1H), 1.72 (s, 1H), 1.68–1.65 (m, 1H), 1.64–1.61 (m, 1H), 1.55–1.53 (m, 1H), 1.50–1.47 (m, 1H), 1.44–1.42 (m, 1H), 1.41 (t, J = 7.1 Hz, 3H), 1.22–1.20 (m, 1H), 1.18 (s, 3H), 1.06 (s, 1H), 1.01 (s, 3H), 0.98 (s, 3H), 0.86 (d, J = 7.1 Hz, 3H). 13C-NMR (100 MHz, CDCl3): (mixture of diasteromers) δ 170.5, 159.5, 153.8, 150.8, 150.54, 150.47, 148.5, 148.4, 148.3, 146.1, 142.5, 127.7, 123.4, 123.3, 118.1, 118.1, 113.5, 113.1, 109.0, 108.9, 106.24, 106.15, 69.5, 61.8, 61.4, 55.33, 55.30, 50.6, 45.5, 43.6, 42.2, 37.92, 37.89, 36.2, 33.8, 33.7, 30.9, 30.8, 30.00, 29.99, 29.7, 23.4, 21.8, 21.7, 18.7, 17.4, 17.2, 17.1, 14.3.

3. Results and Discussion

First, 6β-acetoxyvouacapane 7 was isolated from the Caesalpinia platyloba leaves and purified []. Then, it was subjected to a formylation reaction to obtain aldehyde-6β-acetoxyvouacapane 8, whose synthesis and procedure will be published soon.
Thus, we started by searching for the optimal reaction conditions for the Ugi-azide reaction using aldehyde-vouacapane 8, p-tolouidine (9) as a model reaction, and tert-butyl isocyanide (11). We first performed the reaction using the classical Ugi-azide conditions [,,], with MeOH as the solvent at room temperature. However, the product could not be identified because the aldehyde-6β-acetoxyvouacapane 8 was not soluble in the reaction mixture, and consequently the starting materials were not consumed (entry 1, Table 1). As a second experiment, we performed the reaction using 2,2,2-trifluroethanol as solvent instead of MeOH because of the fact that, in recent years, Ugi-azide reactions have been carried out successfully using this solvent. The reaction proceeded well, resulting in a product with a 33% yield after purification by chromatographic column (entry 2, Table 1). At this point, it was decided to use these conditions, although there are more reaction conditions to be explored such as the use of the microwave reactor [], sonication [], and the use of Lewis acids such as ZnCl2 []. It is also important to mention that in the Ugi-azide reaction, a stereogenic center is formed, so the product obtained was observed by 1H NMR as a mixture of diastereomers in a 50:50 ratio.
Table 1. Optimization of RMC Ugi-azide conditions.
With the optimal reaction conditions previously explored, we proceeded to study the scope of the reaction using amines with different stereoelectronic properties. The tetrazole-vouacapanes 12a–c were obtained in moderate yields (Scheme 1). We also observed by 1H NMR a diastereomeric mixture for each of the target molecules in a 50:50 ratio.
Scheme 1. Synthesis of 1,5-disubstituted tetrazoles-vouacapane 12a–c via Ugi-Azide multicomponent reaction.

4. Conclusions

A small family of pseudo natural products 1,5-disubstituted tetrazoles-vouacapane 12a-c were synthetized in moderate yields by a Ugi-azide multicomponent reaction under mild-reactions conditions. To date, this is the first work where a natural product or natural product derivative has been joined to a non-natural product such as 1,5-disubstituted tetrazole, and beyond the biological relevance that the target molecules present, this work contributes both to the area of natural products and to multicomponent reactions.

Author Contributions

Conceptualization, C.J.C.-G. and R.E.d.R.; methodology, G.S.-G. and J.G.-M.; software, L.C.-G. and M.M.-A.; validation, G.R.-G. and M.M.-A.; formal analysis, L.C.-G. and J.G.-M.; investigation, C.J.C.-G. and M.A.G.-H.; resources, C.J.C.-G. and R.E.d.R.; data curation, G.S.-G. and M.A.G.-H.; writing—original draft preparation, C.J.C.-G. and G.S.-G.; writing—review and editing C.J.C.-G. and L.C.-G.; visualization, M.M.-A. and G.R.-G.; supervision, C.J.C.-G.; project administration, C.J.C.-G. and L.C.-G.; and funding acquisition, C.J.C.-G. All authors have read and agreed to the published version of the manuscript.

Funding

The authors gratefully acknowledged the financial support from Programa para el Desarrollo Profesional Docente, para el Tipo Superior (PRODEP PTC-404), and CIC-UMSNH (14766).

Institutional Review Board Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

Carlos C.-G. is grateful for financial support from Programa para el Desarrollo Profesional Docente, para el Tipo Superior (PRODEP PTC-404), and CIC-UMSNH (14766). Gabriela S.-G. is grateful to CONACYT for scholarships 772950.

Conflicts of Interest

The authors declare no conflict of interest or state.

References

  1. Davisona, E.K.; Brimblea, M.A. Natural product derived privileged scaffolds in drug discovery. Curr. Opin. Chem. Biol. 2019, 52, 1. [Google Scholar] [CrossRef] [PubMed]
  2. Chemat, F.; Vian, M.A.; Cravotto, G. Green Extraction of Natural Products: Concept and Principles. Int. J. Mol. Sci. 2012, 13, 8615–8627. [Google Scholar] [CrossRef] [PubMed]
  3. Koparde, A.; Doijad, R.; Magdum, C. Natural Products in Drug Discovery. In Pharmacognosy-Medicinal Plants; Shagufta, P., Areej, A.-T., Eds.; IntechOpen: London, UK, 2019. [Google Scholar]
  4. Song, L.; Cai, L.; Van der Eycken, E.V. Mic Microwave-Assisted Post-Ugi Reactions for the Synthesis of Polycycles. Molecules 2022, 27, 1. [Google Scholar]
  5. Fouad, M.A.; Abdel-Hamid, H.; Ayoup, M.S. Two decades of recent advances of Ugi reactions: Synthetic and pharmaceutical applications. RSC Adv. 2020, 10, 42644. [Google Scholar] [CrossRef] [PubMed]
  6. Ibarra, I.; Islas-Jácome, A.; González-Zamora, E. Synthesis of polyheterocycles via multicomponent reactions. Org. Biomol. Chem. 2017, 16, 1402. [Google Scholar] [CrossRef] [PubMed]
  7. Gagnon, E.; Bruneau, A.; Hughes, C.E.; de Queiroz, L.P.; Lewis, G.P. A new generic system for the pantropical Caesalpinia group (Leguminosae). PhytoKeys 2016, 71, 1. [Google Scholar] [CrossRef] [PubMed]
  8. Jing, W.; Zhang, X.; Zhou, H.; Wang, Y.; Yang, M.; Long, L.; Gao, H. Naturally occurring cassane diterpenoids (CAs) of Caesalpinia: A systematic review of its biosynthesis, chemistry and pharmacology. Fitoterapia 2019, 134, 226. [Google Scholar] [CrossRef] [PubMed]
  9. Gómez-Hurtado, M.A.; Álvarez-Esquivel, F.E.; Rodríguez-García, G.; Martínez-Pacheco, M.M.; Espinoza-Madrigal, R.M.; Pamatz-Bolaños, T.; Salvador-Hernández, J.L.; García-Gutiérrez, H.A.; Cerda-García-Rojas, C.M.; Joseph-Nathan, P.; et al. Cassane diterpenes from Caesalpinia platyloba. Phytochemistry 2013, 96, 397. [Google Scholar] [CrossRef] [PubMed]
  10. Niño-Pantoja, I.; Gallardo-Alfonzo, A.; Solis-Santos, M.; Ordoñez, M.; Contreras-Celedón, C.; Islas-Jácome, A.; Chacón-García, L.; Cortés-García, C.J. Synthesis of 1,5-Disubstituted Tetrazole−Indolizine Bis-Heterocycles and Their Copper (II) Recognizing Properties. Eur. J. Org. Chem. 2022, 34, e202200230. [Google Scholar] [CrossRef]
  11. Aguilar-Morales, C.M.; Araujo-Huitrado, J.G.; López-Hernández, Y.; Contreras-Celedón, C.; Islas-Jácome, A.; Granados-López, A.J.; Solorio-Alvarado, C.R.; Adrián-López, J.; Chacón-García, L.; Cortés-García, J.C. A One-Pot Six-Component Reaction for the Synthesis of 1,5-Disubstituted Tetrazol-1,2,3-Triazole Hybrids and Their Cytotoxic Activity against the MCF-7 Cell Line. Molecules 2021, 26, 6104. [Google Scholar] [CrossRef] [PubMed]
  12. Aguilar-Morales, C.M.; de Loera, D.; Contreras-Celedón, C.; Cortés-García, C.J.; Chacón-García, L. Synthesis of 1,5-disubstituted Tetrazole-1,2,3 Triazoles Hybrids Via Ugi-azide/CuAAC. Synthetic Commun. 2019, 49, 2086. [Google Scholar] [CrossRef]
  13. Cortes-García, C.J.; Islas-Jácome, A.; Rentería-Gómez, A.; Montaño-Gámez, R. Synthesis of 1,5-disubstituted Tetrazoles Containing a Fragment of the Anticancer Drug Imatinib Via a Microwave-Assisted Ugi-azide Reaction. Monatsh Chem. 2016, 147, 1277. [Google Scholar] [CrossRef]
  14. Unnamatla, M.V.B.; Islas-Jácome, A.; Quezada-Soto, A.; Ramírez-López, S.C.; Flores-Alamo, M.; Gámez-Montaño. Multicomponent One-Pot Synthesis of 3-Tetrazolyl and 3-Imidazo [1,2-a]pyridin Tetrazolo [1,5-a]quinolines. J. Org. Chem. 2016, 81, 10576. [Google Scholar] [CrossRef] [PubMed]
  15. Barreto, A.; Dos Santos, V.; Andrade, C. Consecutive Hydrazino-Ugi-azide Reactions: Synthesis of Acylhydrazines Bearing 1,5-disubstituted Tetrazoles. Beilstein J. Org. Chem. 2017, 13, 2596. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Journal Statistics
Multiple requests from the same IP address are counted as one view.
Download PDF
Aromatic Iodides: Synthesis and Conversion to Heterocycles
Previous
Sulfur-Containing Homo- and Methanofullerenes: Synthesis and Study of Tribological Properties
Next